ASIPP Opioid Guidelines Now Available
Evidence-based clinical practice guidelines for responsible opioid prescribing in non-cancer pain are statements developed to improve the quality of care, patient access, treatment outcomes, appropriateness of care, deficiency and effectiveness, and achieve cost containment by improving the cost benefit ratio. The objectives of these guidelines are to provide clear and concise guidelines to physicians to improve patient access and to avoid diversion and abuse. Part 1 of these guidelines describes evidence assessment (1), whereas Part 2 of these guidelines describes guidance for responsible opioid prescribing.
The objectives of opioid guidelines as issued by the American Society of Interventional Pain Physicians (ASIPP) are to provide guidance for the use of opioids for the treatment of chronic non-cancer pain, to produce consistency in the application of an opioid philosophy among the many diverse groups involved, to improve the treatment of chronic non-cancer pain, and to reduce the incidence of abuse and drug diversion. The focus of these guidelines is to curtail the abuse of opioids without jeopardizing non-cancer pain management with opioids.